Molecular Determinants of Ethionamide Resistance in Clinical Isolates of <i>Mycobacterium tuberculosis</i>

Background: Ethionamide and prothionamide are now included in group C of the WHO recommended drugs for the treatment of tuberculosis resistant to rifampicin and multidrug-resistant tuberculosis. The clinical relevance of ethionamide and prothionamide has increased with the wide spread of resistant t...

Full description

Bibliographic Details

Published in:	Antibiotics
Main Authors:	Anastasia Ushtanit, Elena Kulagina, Yulia Mikhailova, Marina Makarova, Svetlana Safonova, Danila Zimenkov
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Subjects:	tuberculosis drug resistance ethionamide isoniazid perchlozone
Online Access:	https://www.mdpi.com/2079-6382/11/2/133